Governance Telix Pharmaceuticals Limited

TLX

AU000000TLX2

Biotechnology & Medical Research

Market Closed - Australian S.E. Other stock markets 07:12:56 12/06/2026 BST			5-day change	1st Jan Change
13.60 ^AUD	+0.97%		+2.18%	+21.43%

06-03	Telix Pharmaceuticals, United Imaging Healthcare Sign MOU for US Theranostics Collaboration; Shares Down 3%	MT
06-02	Telix Pharmaceuticals, United Imaging Healthcare Sign MOU for US Theranostics Collaboration	MT

Executive Committee: Telix Pharmaceuticals Limited

Manager

Positions heldSince

Christian Behrenbruch

51 year

Chief Executive Officer	02/01/2017
Founder	31/10/2015
Public Communications Contact	02/01/2017

Mary Jessel

Chief Tech/Sci/R&D Officer

Christian Krautkramer

General Counsel

Shomalin Naidoo

Corporate Secretary

01/04/2026

Paul Schaffer

Chief Tech/Sci/R&D Officer

06/04/2025

Darren Patti

54 year

Chief Operating Officer

28/02/2021

Craig Ulrick

Chief Tech/Sci/R&D Officer

31/05/2022

Meredith Crowe

Human Resources Officer

Darren Smith

60 year

Director of Finance/CFO

30/07/2022

Kyahn Williamson

Investor Relations Contact	11/07/2021
Public Communications Contact	11/07/2021

Michael Wheatcroft

Chief Tech/Sci/R&D Officer

David Cade

57 year

Chief Tech/Sci/R&D Officer

31/12/2023

Composition of the Board of Directors: Telix Pharmaceuticals Limited

Director

CommitteesSince

Mark Nelson

66 year

Chairman	02/02/2026
Independent Dir/Board Member	16/09/2017

Marie McDonald

70 year

Audit Committee	21/03/2017
Compensation Committee	13/08/2013
HR Committee	13/08/2013
Nominating Committee	21/03/2017
Compensation Committee Chair	21/03/2017
HR Committee Chair

Jann Skinner

68 year

Compensation Committee	18/06/2018
HR Committee	18/06/2018
Nominating Committee	18/06/2018
Audit Committee Chair	18/06/2018

Maria Rivas

62 year

Audit Committee	30/06/2021
Governance Committee	30/06/2021
Nominating Committee	30/06/2021

William Jellison

68 year

Audit Committee	27/05/2024
Governance Committee

David Gill

71 year

Audit Committee Chair	11/02/2018
Compensation Committee Chair

Christian Behrenbruch

51 year

Director/Board Member

02/01/2017

Latest Appointments: Telix Pharmaceuticals Limited

04-09	Telix Pharmaceuticals Limited Announces Board Appointments, Effective May 11, 2026	CI
04-02	Telix Pharmaceuticals Limited Appoints David Gill as Non-Executive Director, Effective May 11, 2026	CI
02-02	Telix Pharmaceuticals Chair Resigns	MT
02-02	Telix Pharmaceuticals says Mark Nelson appointed interim chair	RE
02-02	Telix Pharmaceuticals Limited Announces Board Changes	CI
28/04/25	Telix Pharmaceuticals Limited Announces Resignation of Anne Whitaker from its Board, Effective 29 April 2025	CI
07/04/25	Telix Appoints Paul Schaffer As Chief Technology Officer	RE

More news

Former Officers and Directors: Telix Pharmaceuticals Limited

Insider

Positions held

SinceUntil

Genevieve Ryan

Corporate Secretary

04/12/2022

01/04/2026

Tiffany Olson

Director/Board Member	30/03/2022	20/05/2025
Chairman	20/05/2025	02/02/2026
Independent Dir/Board Member	30/03/2022	02/02/2026

Harry McCann

Chairman	16/09/2017	20/05/2025
Independent Dir/Board Member	16/09/2017	20/05/2025

Anne Michelle Whitaker

Director/Board Member

06/04/2025

28/04/2025

Andreas Kluge

Director/Board Member	02/01/2017	16/10/2024
Chief Tech/Sci/R&D Officer	02/01/2017	01/06/2020
Founder	31/10/2015	16/10/2024

Colin Hayward

Chief Tech/Sci/R&D Officer

01/06/2020

31/12/2023

Jonathan Barlow

General Counsel	30/09/2018	-
Corporate Officer/Principal	-	30/11/2023

Helen Hovenga

Human Resources Officer

31/07/2021

31/08/2022

Douglas Cubbin

Director of Finance/CFO

16/09/2017

30/07/2022

Gabriel Liberatore

Chief Operating Officer

17/02/2019

30/07/2022

Oliver Buck

Director/Board Member

15/01/2017

17/05/2022

Sunil Kadam

General Counsel

31/01/2022

Tracey Brown

Chief Tech/Sci/R&D Officer	-	-
Corporate Officer/Principal	31/01/2020	-

Richard Zimmermann

Director/Board Member

Melanie Farris

Compliance Officer	-	-
Human Resources Officer	-	-
Corporate Officer/Principal	04/12/2022	-
Corporate Secretary	-	04/12/2022

Lena Moran-Adams

General Counsel

Age distribution of managers

Parity Men Women

Male	21
Female	5

Of which Executive Committee

Male	10
Female	2

Of which Directors

Male	5
Female	2

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.

Employees

1,152

Sector

Biotechnology & Medical Research

More about the company